160 related articles for article (PubMed ID: 18082992)
1. Drug safety, drug quality, drug analysis.
Görög S
J Pharm Biomed Anal; 2008 Sep; 48(2):247-53. PubMed ID: 18082992
[TBL] [Abstract][Full Text] [Related]
2. The sacred cow: the questionable role of assay methods in characterising the quality of bulk pharmaceuticals.
Görög S
J Pharm Biomed Anal; 2005 Jan; 36(5):931-7. PubMed ID: 15620516
[TBL] [Abstract][Full Text] [Related]
3. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
Görög S
Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
[TBL] [Abstract][Full Text] [Related]
4. Is HPLC assay for drug substance a useful quality control attribute?
Hofer JD; Olsen BA; Rickard EC
J Pharm Biomed Anal; 2007 Aug; 44(4):906-13. PubMed ID: 17540527
[TBL] [Abstract][Full Text] [Related]
5. Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques.
Westenberger BJ; Ellison CD; Fussner AS; Jenney S; Kolinski RE; Lipe TG; Lyon RC; Moore TW; Revelle LK; Smith AP; Spencer JA; Story KD; Toler DY; Wokovich AM; Buhse LF
Int J Pharm; 2005 Dec; 306(1-2):56-70. PubMed ID: 16266793
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
7. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
[TBL] [Abstract][Full Text] [Related]
8. Analytical methods for drugs in the next decade.
Zarembo JE
J Assoc Off Anal Chem; 1982 May; 65(3):542-50. PubMed ID: 7096237
[TBL] [Abstract][Full Text] [Related]
9. Chemometric quality control of chromatographic purity.
Laursen K; Frederiksen SS; Leuenhagen C; Bro R
J Chromatogr A; 2010 Oct; 1217(42):6503-10. PubMed ID: 20846660
[TBL] [Abstract][Full Text] [Related]
10. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
Elder DP; Lipczynski AM; Teasdale A
J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
[TBL] [Abstract][Full Text] [Related]
11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
12. Assuring quality of drugs by monitoring impurities.
Ahuja SS
Adv Drug Deliv Rev; 2007 Jan; 59(1):3-11. PubMed ID: 17218038
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the investigation and control of process-related impurities in drug substances.
Argentine MD; Owens PK; Olsen BA
Adv Drug Deliv Rev; 2007 Jan; 59(1):12-28. PubMed ID: 17189658
[TBL] [Abstract][Full Text] [Related]
14. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials.
Gavin PF; Olsen BA; Wirth DD; Lorenz KT
J Pharm Biomed Anal; 2006 Jun; 41(4):1251-9. PubMed ID: 16621411
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
Nageswara Rao R; Kumar Talluri MV; Shinde DD
J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
[TBL] [Abstract][Full Text] [Related]
16. Analysis of purity in 19 drug product tablets containing clopidogrel: 18 copies versus the original brand.
Gomez Y; Adams E; Hoogmartens J
J Pharm Biomed Anal; 2004 Feb; 34(2):341-8. PubMed ID: 15013148
[TBL] [Abstract][Full Text] [Related]
17. Relationship between HPLC precision and number of significant figures when reporting impurities and when setting specifications.
Agut C; Segalini A; Bauer M; Boccardi G
J Pharm Biomed Anal; 2006 May; 41(2):442-8. PubMed ID: 16472956
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
Nageswara Rao R; Narasa Raju A; Narsimha R
J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
[TBL] [Abstract][Full Text] [Related]
19. Why not using capillary electrophoresis in drug analysis?
Holzgrabe U; Brinz D; Kopec S; Weber C; Bitar Y
Electrophoresis; 2006 Jun; 27(12):2283-92. PubMed ID: 16786478
[TBL] [Abstract][Full Text] [Related]
20. Quantitative NMR spectroscopy--applications in drug analysis.
Holzgrabe U; Deubner R; Schollmayer C; Waibel B
J Pharm Biomed Anal; 2005 Aug; 38(5):806-12. PubMed ID: 15893899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
